Andrew D Weinberg

Title: Innovations of Andrew D Weinberg

Introduction

Andrew D Weinberg is a notable inventor based in Portland, Oregon. He has made significant contributions to the field of cancer treatment through his innovative research and patents. With a total of eight patents to his name, Weinberg's work focuses on the identification and utilization of specific T cells for therapeutic purposes.

Latest Patents

One of Weinberg's latest patents involves the utilization of CD39 and CD103 for the identification of human tumor-reactive T cells for cancer treatment. The methods disclosed in this patent include administering a therapeutically effective amount of CD8CD39CD103 T cells to a subject with a tumor. Additionally, the patent outlines methods for isolating a nucleic acid encoding a T cell receptor (TCR) that specifically binds to a tumor cell antigen. This includes isolating CD8CD39CD103 T cells from a sample of a subject with a tumor expressing the antigen and cloning a nucleic acid molecule encoding a TCR from these T cells. Furthermore, the patent describes methods for expanding CD8CD39CD103 T cells and determining if a subject with a tumor will respond to a checkpoint inhibitor by detecting the presence of these T cells in a biological sample.

Career Highlights

Throughout his career, Andrew D Weinberg has worked with various organizations, including Sisters of Providence in Oregon. His innovative approaches have positioned him as a key figure in the development of cancer therapies.

Collaborations

Weinberg has collaborated with notable colleagues such as Arthur A Vandenbark and Thomas Duhen. Their combined expertise has contributed to the advancement of research in the field of immunotherapy.

Conclusion

Andrew D Weinberg's contributions to cancer treatment through his innovative patents and collaborations highlight his significant role in the field of medical research. His work continues to pave the way for advancements in therapeutic strategies for cancer patients.